These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30037426)

  • 1. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
    Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Magnani G; Giugliano RP; Ruff CT; Murphy SA; Nordio F; Metra M; Moccetti T; Mitrovic V; Shi M; Mercuri M; Antman EM; Braunwald E
    Eur J Heart Fail; 2016 Sep; 18(9):1153-61. PubMed ID: 27349698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
    Graham S; Ye S; Qian M; Sanford AR; Di Tullio MR; Sacco RL; Mann DL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Labovitz AJ; Lip GY; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
    PLoS One; 2014; 9(11):e113447. PubMed ID: 25426862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial.
    Teerlink JR; Qian M; Bello NA; Freudenberger RS; Levin B; Di Tullio MR; Graham S; Mann DL; Sacco RL; Mohr JP; Lip GYH; Labovitz AJ; Lee SC; Ponikowski P; Lok DJ; Anker SD; Thompson JLP; Homma S;
    JACC Heart Fail; 2017 Aug; 5(8):603-610. PubMed ID: 28774396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
    Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
    Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
    Nelson WW; Choi JC; Vanderpoel J; Damaraju CV; Wildgoose P; Fields LE; Schein JR
    Am J Cardiol; 2013 Aug; 112(4):509-12. PubMed ID: 23800552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
    Pullicino PM; Qian M; Sacco RL; Freudenberger R; Graham S; Teerlink JR; Mann D; Di Tullio MR; Ponikowski P; Lok DJ; Anker SD; Lip GY; Estol CJ; Levin B; Mohr JP; Thompson JL; Homma S;
    Cerebrovasc Dis; 2014; 38(3):176-81. PubMed ID: 25300706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF.
    Lee TC; Qian M; Liu Y; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Matsumoto K; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Di Tullio MR;
    JACC Heart Fail; 2019 Dec; 7(12):1042-1053. PubMed ID: 31779926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
    Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G
    Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.
    Yimer NS; Abiye AA; Hussen SU; Tadesse TA
    Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.
    Di Tullio MR; Qian M; Thompson JLP; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GYH; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
    ESC Heart Fail; 2018 Oct; 5(5):800-808. PubMed ID: 30015405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK; Lee MJ; Kim JH; Lee JS; Park RW; Kim GM; Chung CS; Lee KH; Kim JS; Lee SY; Bang OY
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1383-1390. PubMed ID: 28412319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.